IGF1 and neoplasm: Insulin resistance promotes tumor cell proliferation, invasion, and metastasis through mechanisms affecting insulin-like growth factor (IGF)-related pathways, inflammatory response, tumor microenvironment, and reactive oxygen species (ROS) (7–9).